Treatment of pathological gambling

Current Opinion in Psychiatry

Volumn 22, Issue 1, 2009, Pages 69-74

  Kit, Sang Leung ^a   Cottler, Linda B ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Nonpharmacological treatment; Pathological gambling; Pharmacological treatment; Pharmacotherapy; Psychotherapy

Indexed keywords

ACETYLCYSTEINE; AMFEBUTAMONE; ATYPICAL ANTIPSYCHOTIC AGENT; CARBAMAZEPINE; FLUVOXAMINE; HALOPERIDOL; LITHIUM; LITHIUM CARBONATE; MODAFINIL; NALMEFENE; NALTREXONE; OLANZAPINE; PLACEBO; TOPIRAMATE; VALPROIC ACID;

BIPOLAR DISORDER; CLINICAL TRIAL; COGNITIVE THERAPY; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; DRUG APPROVAL; DRUG EFFICACY; DRUG MECHANISM; DRUG MEGADOSE; EXTRAPYRAMIDAL SYMPTOM; FOOD AND DRUG ADMINISTRATION; HUMAN; INTERMETHOD COMPARISON; MOTIVATION; PATHOLOGICAL GAMBLING; REVIEW; TREATMENT OUTCOME; UNSPECIFIED SIDE EFFECT; VIDEOCONFERENCING;

GAMBLING; HUMANS; IMPULSE CONTROL DISORDERS; NARCOTIC ANTAGONISTS; PSYCHOTHERAPY; PSYCHOTROPIC DRUGS;

EID: 57749194695     PISSN: 09517367     EISSN: None     Source Type: Journal    
DOI: 10.1097/YCO.0b013e32831575d9     Document Type: Review

References (47)

1. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders: DSM-IV. Fourth edition. Washington, District of Columbia: American Psychiatric Association, 1994.
2. Cunningham-Williams RM, Abdallah AB, Callahan C, Cottler L. Problem gambling and violence among community-recruited female substance abusers. Psychol Addict Behav 2007; 21:239-243.
3. Cunningham-Williams RM, Grucza RA, Cottler LB, et al. Prevalence and predictors of pathological gambling: results from the St. Louis personality, health and lifestyle (SLPHL) study. J Psychiatr Res 2005; 39:377-390.
4. Cunningham-Williams RM, Cottler LB, Compton WM, et al. Problem gambling and comorbid psychiatric and substance use disorders among drug users recruited from drug treatment and community settings. J Gambl Stud 2000; 16:347-376.
5. Cunningham-Williams RM, Cottler LB, Compton WM 3rd, Spitznagel EL. Taking chances: problem gamblers and mental health disorders-results from the St. Louis Epidemiologic Catchment Area Study. Am J Public Health 1998; 88:1093-1096.
6. Kessler RC, Hwang I, Labrie R, et al. DSM-IV pathological gambling in the National Comorbidity Survey Replication. Psychol Med 2008; 7:1-10.
7. Lesieur H. Costs and treatment of pathological gambling. Ann Am Acad Pol Soc Sci 1998; 556:157-171.
8. Dickson-Swift VA, James EL, Kippen S. The experience of living with a problem gambler: spouse and partners speak out. J Gambl Issues 2005; 13:1-22.
9. Muelleman RL, DenOtter T, Wadman MC, et al. Problem gambling in the partner of the emergency department patient as a risk factor for intimate partner violence. J Emerg Med 2002; 23:307-312.
10. Lorenz VC, Shuttlesworth DE. The impact of pathological gambling on the spouse of the gambler. J Commun Psychol 1983; 11:67-76.
11. Kim SW. Opioid antagonists in the treatment of impulse-control disorders. J Clin Psychiatry 1998; 59:159-164.
12. Berridge KC. Food reward: brain substrates of wanting and liking. Neurosci Biobehav Rev 1996; 20:1-25.
13. Volkow ND, Fowler JS, Wolf AP, et al. Changes in brain glucose metabolism in cocaine dependence and withdrawal. Am J Psychiatry 1991; 148:621-626.
14. Modesto-Lowe V, Van Kirk J. Clinical uses of naltrexone: a review of the evidence. Exp Clin Psychopharmacol 2002; 10:213-227.
15. Kim SW, Grant JE. An open naltrexone treatment study in pathological gambling disorder. Int Din Psychopharmacol 2001; 16:285-289.
16. Kim SW, Grant JE, Adson DE, Shin YC. Double-blind naltrexone and placebo comparison study in the treatment of pathological gambling. Biol Psychiatry 2001; 49:914-921.
17. Grant JE, Kim SW, Hartman BK. A double-blind placebo-controlled study of the opiate antagonist naltrexone in the treatment of pathological gambling urges. J Clin Psychiatry 2008; 69:783-789. This study demonstrated the efficacy of naltrexone in treating pathological gambling in a double-blind, placebo-controlled, confirmatory study.
18. Grant JE, Kim SW, Hollander E, Potenza MN. Predicting response to opiate antagonists and placebo in the treatment of pathological gambling. Psychopharmacology (Berl) 2008; DOI: 10.1007/s00213-008-1235-3. The study examined the clinical variables associated with opiate antagonist treatment outcome based on the data collected in two previous clinical studies (N = 284).
19. McElroy SL, Pope HG Jr, Keck PE Jr, et al. Are impulse-control disorders related to bipolar disorder? Compr Psychiatry 1996; 37:229-240.
20. Pallanti S, Quercioli L, Sood E, Hollander E. Lithium and valproate treatment of pathological gambling: a randomized single-blind study. J Clin Psychiatry 2002; 63:559-564.
21. Haller R, Hinterhuber H. Treatment of pathological gambling with carbamazepine. Pharmacopsychiatry 1994; 27:129.
22. Moskowitz JA. Lithium and lady luck; use of lithium carbonate in compulsive gambling. N Y State J Med 1980; 80:785-788.
23. Hollander E, Pallanti S, Allen A, et al. Does sustained-release lithium reduce impulsive gambling and affective instability versus placebo in pathological gamblers with bipolar spectrum disorders? Am J Psychiatry 2005; 162:137-145.
24. Dannon PN, Lowengrub K, Gonopolski Y, et al. Topiramate versus fluvoxamine in the treatment of pathological gambling: a randomized, blind-rater comparison study. Clin Neuropharmacol 2005; 28:6-10.
25. Black DW, Shaw MC, Allen J. Extended release carbamazepine in the treatment of pathological gambling: an open-label study. Prog Neuropsychopharmacol Biol Psychiatry 2008; 32:1191-1194. This paper showed that carbamazepine (a mood stabilizer) might be used to reduce gambling urges and gambling behaviors in an open label clinical trial.
26. Nicolato R, Romano-Silva MA, Correa H, et al. Lithium and topiramate association in the treatment of comorbid pathological gambling and bipolar disorder. Aust N Z J Psychiatry 2007; 41:628. This is a case report on the combined use of lithium and topiramate in the treatment of a female pathological gambler with bipolar disorder.
27. Fong T, Kalechstein A, Bernhard B, et al. A double-blind, placebo-controlled trial of olanzapine for the treatment of video poker pathological gamblers. Pharmacol Biochem Behav 2008; 89:298-303.
28. McElroy SL, Nelson EB, Welge JA, et al. Olanzapine in the treatment of pathological gambling: a negative randomized placebo-controlled trial. J Clin Psychiatry 2008; 69:433-440.
29. Bymaster FP, Calligaro DO, Falcone JF, et al. Radioreceptor binding profile of the atypical antipsychotic olanzapine. Neuropsychopharmacology 1996; 14:87-96.
30. Bymaster FP, Hemrick-Luecke SK, Perry KW, Fuller RW. Neurochemical evidence for antagonism by olanzapine of dopamine, serotonin, alpha 1-adrenergic and muscarinic receptors in vivo in rats. Psychopharmacology (Berl) 1996; 124:87-94.
31. Meltzer HY, Fibiger HC. Olanzapine: a new typical antipsychotic drug. Neuropsychopharmacology 1996; 14:83-85.
32. Dannon PN, Lowengrub K, Musin E, et al. 12-month follow-up study of drug treatment in pathological gamblers: a primary outcome study. J Clin Psychopharmacol 2007; 27:620-624. This study compared the 12-month treatment outcome of fluvoxamine, naltrexone, topiramate and bupropion SR using clinical data collected in previous studies. However, this study is suspect because it did not include placebo-controlled groups.
33. Grant JE, Kim SW, Odlaug BL. N-acetyl cysteine, a glutamate-modulating agent, in the treatment of pathological gambling: a pilot study. Biol Psychiatry 2007; 62:652-657. This is the first study using a glutamate-modulating agent (N-acetyl cysteine) to treat pathological gambling. Individuals showed a significant reduction in gambling urges and behaviors after the treatment.
34. Zack M, Poulos CX. Amphetamine primes motivation to gamble and gambling-related semantic networks in problem gamblers. Neuropsychopharmacology 2004; 29:195-207.
35. Zack M, Poulos CX. A D2 antagonist enhances the rewarding and priming effects of a gambling episode in pathological gamblers. Neuropsychopharmacology 2007; 32:1678-1686.
36. Zack M, Poulos CX. Effects of the atypical stimulant modafinil on a brief gambling episode in pathological gamblers with high vs. low impulsivity. J Psychopharmacol 2008; DOI: 10.1177/0269881108091072. This study showed the differentiated effects of modafinil (an atypical stimulant) on pathological gamblers with high vs. low impulsivity.
37. Petry NM, Ammerman Y, Bohl J, et al. Cognitive-behavioral therapy for pathological gamblers. J Consult Clin Psychol 2006; 74:555-567.
38. Toneatto T, Ladoceur R. Treatment of pathological gambling: a critical review of the literature. Psychol Addict Behav 2003; 17:284-292.
39. Petry NM, Weinstock J, Ledgerwood DM, Morasco B. A randomized trial of brief interventions for problem and pathological gamblers. J Consult Clin Psychol 2008; 76:318-328. This study found that brief interventions were more effective than the motivational enhancement therapy (MET) and the treatment using both MET and cognitive-ehavioral therapy.
40. Petry NM, Litt MD, Kadden R, Ledgerwood DM. Do coping skills mediate the relationship between cognitive-behavioral therapy and reductions in gambling in pathological gamblers? Addiction 2007; 102:1280-1291. This study showed that the effectiveness of cognitive-behavioral therapy in the treatment of pathological gambling might be mediated by the changes in coping skills.
41. Dowling N, Smith D, Thomas T. A comparison of individual and group cognitive-behavioural treatment for female pathological gambling. Behav Res Ther 2007; 45:2192-2202.
42. Toneatto T, Dragonetti R. Effectiveness of community-based treatment for problem gambling: a quasi-experimental evaluation of cognitive-behavioral vs. twelve-step therapy. Am J Addict 2008; 17:298-303.
43. Oakes J, Battersby MW, Pols RG, Cromarty P. Exposure therapy for problem gambling via videoconferencing: a case report. J Gambl Stud 2008; 24:107-118. This case study reported the use of videoconferencing in delivering ongoing supervision or treatment to a female pathological gambler over a follow-up period of 4 years.
44. Satir V, Banmen J, Gerber J, Gomori M. The Satir Model: family therapy and beyond. Palo Alto: Science and Behavior Books; 1991.
45. Lee BK, Rovers M, 'Bringing torn lives together again': effects of the first congruence couple therapy training application to clients in pathological gambling. Int Gambl Studies 2008; 8:113-129. This paper reported the positive treatment outcomes of pathological gambling using a modified family therapy approach. However, the study did not include a control group and the results may be biased.
46. Pallesen S, Mitsem M, Kvale G, et al. Outcome of psychological treatments of pathological gambling: a review and meta-analysis. Addiction 2005; 100:1412-1422.
47. Pallesen S, Molde H, Amestad HM, et al. Outcome of pharmacological treatments of pathological gambling: a review and meta-analysis. J Clin Psychopharmacol 2007; 27:357-364. This study found that pharmacological treatments were more effective than no treatment/placebo in a meta-analysis involving 16 pharmacological treatment studies.